Choose antibacterial carefully when treating methicillin-resistant Staphylococcus aureus diabetic foot infections

摘要

The proper use of antibacterials is essential to successfully treat methicillin-resistant Staphylococcus aureus (MRSA) in diabetic foot infections. Mild to moderate MRSA infections may be treated with cotrimoxazole (trimethoprim/sulfamethoxazole), doxycycline or clindamycin in the outpatient setting. However, severe MRSA infections require inpatient treatment with a regimen that includes daptomycin, a glycopeptide or linezolid.